NEXGEN PHARMA FDA Approval ANDA 204054

ANDA 204054

NEXGEN PHARMA

FDA Drug Application

Application #204054

Application Sponsors

ANDA 204054NEXGEN PHARMA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL2.5MG0MECAMYLAMINE HYDROCHLORIDEMECAMYLAMINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2013-03-19

Submissions Property Types

ORIG1Null1

CDER Filings

LGM PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204054
            [companyName] => LGM PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"MECAMYLAMINE HYDROCHLORIDE","activeIngredients":"MECAMYLAMINE HYDROCHLORIDE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/19\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2013-03-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.